KR20240082401A - Il-2 전구약물 - Google Patents

Il-2 전구약물 Download PDF

Info

Publication number
KR20240082401A
KR20240082401A KR1020247014914A KR20247014914A KR20240082401A KR 20240082401 A KR20240082401 A KR 20240082401A KR 1020247014914 A KR1020247014914 A KR 1020247014914A KR 20247014914 A KR20247014914 A KR 20247014914A KR 20240082401 A KR20240082401 A KR 20240082401A
Authority
KR
South Korea
Prior art keywords
tumor
fold
prodrug
inducible
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020247014914A
Other languages
English (en)
Korean (ko)
Inventor
호세 안드레 샐머론-가르시아
윌리엄 윈스턴
대니얼 히클린
신디아 사이델-두간
헤더 브로드킨
크리스토퍼 니르쉴
티지아나 카파렐리
Original Assignee
웨어울프 세라퓨틱스, 인크.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 웨어울프 세라퓨틱스, 인크. filed Critical 웨어울프 세라퓨틱스, 인크.
Publication of KR20240082401A publication Critical patent/KR20240082401A/ko
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
KR1020247014914A 2021-10-08 2022-10-07 Il-2 전구약물 Pending KR20240082401A (ko)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202163253964P 2021-10-08 2021-10-08
US63/253,964 2021-10-08
US202163290941P 2021-12-17 2021-12-17
US63/290,941 2021-12-17
US202263328524P 2022-04-07 2022-04-07
US63/328,524 2022-04-07
PCT/US2022/077772 WO2023060242A1 (en) 2021-10-08 2022-10-07 Il-2 prodrug

Publications (1)

Publication Number Publication Date
KR20240082401A true KR20240082401A (ko) 2024-06-10

Family

ID=83978868

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020247014914A Pending KR20240082401A (ko) 2021-10-08 2022-10-07 Il-2 전구약물

Country Status (6)

Country Link
US (1) US20240374687A1 (https=)
EP (1) EP4412712A1 (https=)
JP (1) JP2024538707A (https=)
KR (1) KR20240082401A (https=)
CA (1) CA3233893A1 (https=)
WO (1) WO2023060242A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025250977A1 (en) * 2024-05-31 2025-12-04 Werewolf Therapeutics, Inc. Cancer therapy using il-2 prodrug
WO2026072455A1 (en) * 2024-09-26 2026-04-02 Werewolf Therapeutics, Inc. Single domain human serum albumin antibodies

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210130430A1 (en) * 2018-05-14 2021-05-06 Werewolf Therapeutics, Inc. Activatable cytokine polypeptides and methods of use thereof
BR112022009110A2 (pt) 2019-11-14 2022-07-26 Werewolf Therapeutics Inc Polipeptídeos de citocina ativáveis e métodos de uso destes

Also Published As

Publication number Publication date
CA3233893A1 (en) 2023-04-13
EP4412712A1 (en) 2024-08-14
WO2023060242A1 (en) 2023-04-13
US20240374687A1 (en) 2024-11-14
JP2024538707A (ja) 2024-10-23

Similar Documents

Publication Publication Date Title
CN110831961B (zh) 用于免疫疗法的cd19组合物和方法
Zhang et al. Low-dose IL-2 therapy in autoimmune diseases: An update review
US11421010B2 (en) T cells expressing membrane-anchored IL-12 for the treatment of cancer
US11963980B2 (en) Activated CD26-high immune cells and CD26-negative immune cells and uses thereof
AU2021221880A1 (en) Combination immune therapy and cytokine control therapy for cancer treatment
KR20220068240A (ko) 암 치료를 위한 암 요법과 사이토카인 조절 요법의 조합
TW202016139A (zh) Bcma 嵌合抗原受體及其用途
IL261008B2 (en) Combined immunotherapy and cytokine control therapy for cancer treatment
US10071118B2 (en) Compositions and methods for treating peritoneal cancers
KR20200071753A (ko) 키메라 항원 수용체 면역요법제를 투여하는 방법
US20240374687A1 (en) Il-2 prodrug
EP4196133A2 (en) Methods and compositions for stimulating gamma delta t cells
WO2017177063A1 (en) Use of heterodimeric il-15 in adoptive cell transfer
US20190144825A1 (en) Methods of Treating Cancer and Infectious Diseases Using Cell Based Therapies
US20220177599A1 (en) Dual chimeric antigen receptor targeting epcam and icam-1
JP2024536217A (ja) 操作されたｎｋ細胞及びその使用
KR20230088768A (ko) 췌관 샘암종 치료를 위한 병용 면역치료학적 방법 및 조성물
KR20230096049A (ko) 편평 세포 암종 치료용 IL-2/IL-15Rβγ 작용제
TW202132326A (zh) Hla限制性hormad1 t細胞受體及其用途
US20240209058A1 (en) Mesothelin-specific T cell Receptors and Methods of Using Same
KR20260026020A (ko) Cd74 car-t 치료요법 및 이의 사용 방법
JP2024527963A (ja) ユニバーサル受容体免疫細胞療法

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-NAP-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000